Response to the letter by Langabeer on "Retrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteria"

scientific article published on 30 March 2020

Response to the letter by Langabeer on "Retrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteria" is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.5045/BR.2020.55.1.68
P932PMC publication ID7106110
P698PubMed publication ID32269980

P2093author name stringIk-Chan Song
P2860cites workJAK2(V617F): Prevalence in a large Chinese hospital populationQ35615806
JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patientsQ80993963
Implications of Janus Kinase 2 Mutation in Embolic Stroke of Unknown SourceQ90596022
P275copyright licenseCreative Commons Attribution-NonCommercial 4.0 InternationalQ34179348
P6216copyright statuscopyrightedQ50423863
P433issue1
P921main subjectWorld Health OrganizationQ7817
P304page(s)68
P577publication date2020-03-30
P1433published inBlood researchQ26842305
P1476titleResponse to the letter by Langabeer on "Retrospective screening for Philadelphia-negative myeloproliferative neoplasms in patients with cerebral infarctions as revealed using the revised 2016 World Health Organization diagnostic criteria"
P478volume55

Search more.